Barclays’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-211,800
Closed -$4.26M – 5064
2022
Q4
$4.26M Buy
+211,800
New +$4.53M ﹤0.01% 1739

Other funds holding AEHR

Barclays's AEHR Position: Q3 2026 in Review

Barclays increased its Aehr Test Systems (AEHR) stake by 2.4% in Q3 2026, buying an estimated $221K and bringing the position to 103,660 shares worth $10.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1624.

Barclays first reported a position in AEHR in Q3 2021 and has held it in 19 quarters since. 300 funds tracked by Wall St. Rank hold AEHR as of Q3 2026.

  • Barclays held 103,660 shares of Aehr Test Systems worth $10.3M as of Q3 2026.
  • Barclays bought 2,411 Aehr Test Systems shares in Q3 2026, an estimated $221K.
  • Aehr Test Systems made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #1624 holding.
  • Barclays first reported a position in Aehr Test Systems in Q3 2021 and has held it in 19 quarters since.
  • 300 funds tracked by Wall St. Rank held Aehr Test Systems as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.